Clough Capital Partners’s Gilead Sciences GILD Stock Holding History

Clough Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$796K	Hold	6,300	–	–	0.06%	101
2026 Q1	$878K	Hold	6,300	–	–	0.08%	91
2025 Q4	$773K	Hold	6,300	–	–	0.07%	107
2025 Q3	$699K	Hold	6,300	–	–	0.06%	104
2025 Q2	$698K	Hold	6,300	–	–	0.07%	95
2025 Q1	$706K	Hold	6,300	–	–	0.09%	86
2024 Q4	$582K	Hold	6,300	–	–	0.07%	99
2024 Q3	$528K	Hold	6,300	–	–	0.05%	117
2024 Q2	$432K	Hold	6,300	–	–	0.05%	108
2024 Q1	$461K	Hold	6,300	–	–	0.05%	111
2023 Q4	$510K	Sell	6,300 -1,400	-18%	-$109K	0.06%	136
2023 Q3	$577K	Hold	7,700	–	–	0.06%	126
2023 Q2	$593K	Hold	7,700	–	–	0.06%	145
2023 Q1	$639K	Hold	7,700	–	–	0.07%	140
2022 Q4	$661K	Buy	+7,700	New	+$610K	0.07%	138
2020 Q3	–	Sell	-103,200	Closed	-$7.94M	–	131
2020 Q2	$7.94M	Sell	103,200 -83,800	-45%	-$6.42M	0.78%	50
2020 Q1	$14M	Buy	+187,000	New	+$12.9M	1.39%	23
2017 Q1	–	Sell	-248,322	Closed	-$17.8M	–	162
2016 Q4	$17.8M	Buy	248,322 +118,822	+92%	+$8.83M	1.18%	29
2016 Q3	$10.2M	Buy	129,500 +61,900	+92%	+$5.03M	0.53%	64
2016 Q2	$5.64M	Buy	+67,600	New	+$6M	0.3%	101
2015 Q3	–	Sell	-114,316	Closed	-$13.4M	–	209
2015 Q2	$13.4M	Sell	114,316 -77,140	-40%	-$8.43M	0.51%	73
2015 Q1	$18.8M	Buy	+191,456	New	+$19.4M	0.62%	70
2014 Q2	–	Sell	-283,046	Closed	-$20.1M	–	206
2014 Q1	$20.1M	Sell	283,046 -39,200	-12%	-$3.07M	0.63%	61
2013 Q4	$24.2M	Sell	322,246 -9,600	-3%	-$668K	0.8%	45
2013 Q3	$20.9M	Buy	331,846 +8,000	+2%	+$478K	0.65%	59
2013 Q2	$16.6M	Buy	+323,846	New	+$16.9M	0.55%	65

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Clough Capital Partners's GILD Position: Q2 2026 in Review

Clough Capital Partners held its Gilead Sciences (GILD) position steady in Q2 2026 at 6,300 shares worth $796K. The position accounts for 0.06% of the portfolio, ranked #101.

Clough Capital Partners first reported a position in GILD in Q2 2013 and has held it in 26 quarters since. The position peaked at $24.2M in Q4 2013. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Clough Capital Partners held 6,300 shares of Gilead Sciences worth $796K as of Q2 2026.
Clough Capital Partners left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.06% of Clough Capital Partners's portfolio in Q2 2026, its #101 holding.
Clough Capital Partners first reported a position in Gilead Sciences in Q2 2013 and has held it in 26 quarters since.
Clough Capital Partners's Gilead Sciences position peaked at $24.2M in Q4 2013.
2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Clough Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.